Loading…
ASPIRIN is a brand name for Aspirin (also known as Acetylsalicylic Acid). The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery.
Verbatim from this product's MHRA label. Tap a section to expand.
For the management of cardiovascular or cerebrovascular disease:
The advice of a doctor should be sought before commencing therapy for the first time. The usual dosage, for long term use, is 75-150 mg once daily. In some Circumstances a higher dose may be appropriate, especially in the short term, and up to 300 mg a day may be used on the advice of a doctor.
In general, acetylsalicylic acids should be used with caution in elderly patients who are more prone to adverse events. 4). Treatment should be reviewed at regular intervals. These tablets should be taken orally with a drink of water.
Children under 16 years:
Aspirin 75mg tablets are not indicated for use in children and young people less than 16 years of age (see ‘Special Warnings and Precautions for Use’).
Children 16 years or over:
As for adults and the elderly.
Side effects are grouped on the basis of System Organ Class. Within each system organ class the frequencies are defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data) Blood and lymphatic system disorders Common: Increased bleeding tendencies.
Rare:
Thrombocytopenia, granulocytosis, aplastic anaemia.
Not known:
Cases of bleeding with prolonged bleeding time such as epistaxis, gingival bleeding. Symptoms may persist for a period of 4–8 days after acetylsalicylic acid discontinuation. As a result there may be an increased risk of bleeding during surgical procedures.
Existing (haematemesis, melaena) or occult gastrointestinal bleeding, which may lead to iron deficiency anaemia (more common at higher doses).
Immune system Disorders Rare:
Hypersensitivity reactions, angio-oedema, allergic oedema, anaphylactic reactions including shock.
Metabolism and digestive system disorders Not known:
Hyperuricemia.
Nervous system disorders Rare:
Intracranial haemorrhage Not known: Headache, vertigo.
Ear and labyrinth disorders Not known:
Reduced hearing ability; tinnitus.
Vascular disorders Rare:
Hemorrhagic vasculitis.
Aspirin 75mg tablets are not suitable for use as an anti-inflammatory/ analgesic/ antipyretic. Recommended for use in adults and adolescents from 16 years of age. This medicinal product is not recommended for use in adolescents/children under 16 years unless the expected benefits outweigh the risks.
Acetylsalicylic acid may be a contributory factor in the causation of Reye's syndrome in some children. g. tooth extraction). Use with caution before surgery, including tooth extraction. Temporary discontinuation of treatment may be necessary.
Aspirin 75mg tablets is not recommended during menorrhagia where it may increase menstrual bleeding. Aspirin 75mg tablets is to be used with caution in cases of hypertension and when patients have a past history of gastric or duodenal ulcer or haemorrhagic episodes or are undergoing therapy with anticoagulants.
Aspirin may induce gastro-intestinal haemorrhage, occasionally major. Patients should report any unusual bleeding symptoms to their physician. If gastrointestinal bleeding or ulceration occurs the treatment should be withdrawn. Acetylsalicylic acid should be used with caution in patients with moderately impaired renal or hepatic function (contraindicated if severe), or in patients who are dehydrated since the use of NSAIDs may result in deterioration of renal function.
Liver function tests should be performed regularly in patients presenting slight or moderate hepatic insufficiency. Acetylsalicylic acid may promote bronchospasm and asthma attacks or other hypersensitivity reactions. Risk factors are existing asthma, hay fever, nasal polyps or chronic respiratory diseases.
g. with skin reactions, itching or urticaria). 8). Aspirin 75mg tablets should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity. 2). Where prolonged therapy is required, patients should be reviewed regularly.
g. certain asthma patients who may suffer an attack or faint and certain patients who may suffer from bronchospasm, rhinitis and urticaria) and to any of the excipients or non-steroidal anti-inflammatory drugs. Not to be given to children under 16 years unless specifically indicated (eg.
5).
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Aspirin in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Respiratory, thoracic and mediastinal disorders Uncommon:
Rhinitis, dyspnoea.
Rare:
Bronchospasm, asthma attacks.
Reproductive System and mammary Rare:
Menorrhagia disorders Gastrointestinal disorders Common: Dyspepsia.
Rare:
Severe gastrointestinal haemorrhage, nausea, vomiting.
Not known:
Gastric or duodenal ulcers and perforation, diarrhoea.
Hepatobiliary disorders Not known:
Hepatic insufficiency Skin and subcutaneous tissue disorders Uncommon: Urticaria.
Rare:
Steven-Johnsons syndrome, Lyells syndrome, purpura, erythema nodosum, erythema multiforme.
Renal and urinary tract disorders Not known:
Impaired renal function, salt and water retention. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
uk/yellowcard.
e. 5). If the combination cannot be avoided, close observation for signs of bleeding is recommended. 5). Acetylsalicylic acid in low doses reduces uric acid excretion. 5). 5). 6). Aspirin 75mg tablet contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.